<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27618897</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1419</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms17091419</ELocationID><Abstract><AbstractText>The nontoxic heat-labile toxin (LT) B subunit (LTB) was used as mucosal adjuvant experimentally. However, the mechanism of LTB adjuvant was still unclear. The LTB and enterovirus 71 (EV71) VP1 subunit (EVP1) were constructed in pET32 and expressed in E. coli BL21, respectively. The immunogenicity of purified EVP1 and the adjuvanticity of LTB were evaluated via intranasal immunization EVP1 plus LTB in Balb/c mice. In order to elucidate the proteome change triggered by the adjuvant of LTB, the proteomic profiles of LTB, EVP1, and LTB plus EVP1 were quantitatively analyzed by iTRAQ-LC-MS/MS (isobaric tags for relative and absolute quantitation; liquid chromatography-tandem mass spectrometry) in murine macrophage RAW264.7. The proteomic data were analyzed by bioinformatics and validated by western blot analysis. The predicted protein interactions were confirmed using LTB pull-down and the LTB processing pathway was validated by confocal microscopy. The results showed that LTB significantly boosted EVP1 specific systematic and mucosal antibodies. A total of 3666 differential proteins were identified in the three groups. Pathway enrichment of proteomic data predicted that LTB upregulated the specific and dominant MAPK (mitogen-activated protein kinase) signaling pathway and the protein processing in endoplasmic reticulum (PPER) pathway, whereas LTB or EVP1 did not significantly upregulate these two signaling pathways. Confocal microscopy and LTB pull-down assays confirmed that the LTB adjuvant was endocytosed and processed through endocytosis (ENS)-lysosomal-endoplasmic reticulum (ER) system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Biochemistry and Molecular Biology, The Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China. 15086785450@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yongping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Biochemistry and Molecular Biology, The Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China. yongpingm@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Huicong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Key Laboratory of Biochemistry and Molecular Biology, The Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China. zhczb@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Mingjun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Life Science, Chongqing Medical University, Chongqing 400016, China. wmjun20019688@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001427">Bacterial Toxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004768">Enterotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029968">Escherichia coli Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>D9K3SN2LNY</RegistryNumber><NameOfSubstance UI="C027538">heat-labile enterotoxin, E coli</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001427" MajorTopicYN="N">Bacterial Toxins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004768" MajorTopicYN="N">Enterotoxins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029968" MajorTopicYN="N">Escherichia coli Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018613" MajorTopicYN="N">Microscopy, Confocal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ETEC (Enterotoxigenic Escherichia coli)</Keyword><Keyword MajorTopicYN="N">LTB (labile toxin B subunit)</Keyword><Keyword MajorTopicYN="N">enterovirus 71 VP1</Keyword><Keyword MajorTopicYN="N">iTRAQ</Keyword><Keyword MajorTopicYN="N">immune</Keyword><Keyword MajorTopicYN="N">mucosal adjuvant</Keyword><Keyword MajorTopicYN="N">proteome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27618897</ArticleId><ArticleId IdType="pmc">PMC5037698</ArticleId><ArticleId IdType="doi">10.3390/ijms17091419</ArticleId><ArticleId IdType="pii">ijms17091419</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Donaldson D.S., Tong K.K., Williams N.A. Mucosal administration of the B subunit of E. coli heat-labile enterotoxin promotes the development of Foxp3-expressing regulatory T-cells. Mucosal Immunol. 2011;4:227&#x2013;238. doi: 10.1038/mi.2010.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2010.65</ArticleId><ArticleId IdType="pubmed">20944556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E., Merritt E.A., Zhang Z., Pickens J.C., Roach C., Ahn M., Hol W.G. Exploration of the GM1 receptor-binding site of heat-labile enterotoxin and cholera toxin by phenyl-ring-containing galactose derivatives. Acta Crystallogr. D Biol. Crystallogr. 2001;57:201&#x2013;212. doi: 10.1107/S0907444900016814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444900016814</ArticleId><ArticleId IdType="pubmed">11173465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fingerut E., Gutter B., Meir R., Eliahoo D., Pitcovski J. Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast. Vaccine. 2005;23:4685&#x2013;4696. doi: 10.1016/j.vaccine.2005.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2005.03.050</ArticleId><ArticleId IdType="pubmed">15951067</ArticleId></ArticleIdList></Reference><Reference><Citation>Freytag L.C., Clements J.D. Mucosal adjuvants. Vaccine. 2005;23:1804&#x2013;1813. doi: 10.1016/j.vaccine.2004.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2004.11.010</ArticleId><ArticleId IdType="pubmed">15734046</ArticleId></ArticleIdList></Reference><Reference><Citation>Leach S., Clements J.D., Kaim J., Lundgren A. The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T-cells specific for bacterial vaccine antigens. PLoS ONE. 2012;7:1419. doi: 10.1371/journal.pone.0051718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051718</ArticleId><ArticleId IdType="pmc">PMC3527457</ArticleId><ArticleId IdType="pubmed">23284753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K.W., Wilson A.D., Hirst T.R., Morgan A.J. The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines. J. Virol. 2003;77:4298&#x2013;4305. doi: 10.1128/JVI.77.7.4298-4305.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.7.4298-4305.2003</ArticleId><ArticleId IdType="pmc">PMC150673</ArticleId><ArticleId IdType="pubmed">12634387</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar D.G., Hirst T.R., Snider D.P. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin. Infect. Immun. 2001;69:3476&#x2013;3482. doi: 10.1128/IAI.69.5.3476-3482.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.69.5.3476-3482.2001</ArticleId><ArticleId IdType="pmc">PMC98315</ArticleId><ArticleId IdType="pubmed">11292779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Luo Y., Huang X., Song F., Liu G. Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli. Microbiology. 2012;158:498&#x2013;504. doi: 10.1099/mic.0.049932-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/mic.0.049932-0</ArticleId><ArticleId IdType="pubmed">22053005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y. Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants. Expert Rev. Vaccines. 2016 doi: 10.1080/14760584.2016.1182868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2016.1182868</ArticleId><ArticleId IdType="pubmed">27118519</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Hora V.P., Conceicao F.R., Dellagostin O.A., Doolan D.L. Non-toxic derivatives of LT as potent adjuvants. Vaccine. 2011;29:1538&#x2013;1544. doi: 10.1016/j.vaccine.2010.11.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.11.091</ArticleId><ArticleId IdType="pubmed">21163247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara Y., Iwasaki T., Asanuma H., Sato Y., Sata T., Aizawa C., Kurata T., Tamura S. Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain. Vaccine. 2001;19:1652&#x2013;1660. doi: 10.1016/S0264-410X(00)00412-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(00)00412-6</ArticleId><ArticleId IdType="pubmed">11166888</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmgren J., Bourgeois L., Carlin N., Clements J., Gustafsson B., Lundgren A., Nygren E., Tobias J., Walker R., Svennerholm A.M. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine. 2013;31:2457&#x2013;2464.</Citation><ArticleIdList><ArticleId IdType="pubmed">23541621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez J., Holmgren J. Cholera toxin&#x2014;A foe &amp; a friend. Indian J. Med. Res. 2011;133:153&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3089046</ArticleId><ArticleId IdType="pubmed">21415489</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmgren J., Elwing H., Fredman P., Strannegard O., Svennerholm L. Gangliosides as receptors for bacterial toxins and Sendai virus. Adv. Exp. Med. Biol. 1980;125:453&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">6244724</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashar T.O., Webb H.M., Eaglestone S., Williams N.A., Hirst T.R. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. USA. 1996;93:226&#x2013;230. doi: 10.1073/pnas.93.1.226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.1.226</ArticleId><ArticleId IdType="pmc">PMC40211</ArticleId><ArticleId IdType="pubmed">8552610</ArticleId></ArticleIdList></Reference><Reference><Citation>De Haan L., Verweij W.R., Feil I.K., Holtrop M., Hol W.G., Agsteribbe E., Wilschut J. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology. 1998;94:424&#x2013;430. doi: 10.1046/j.1365-2567.1998.00535.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.1998.00535.x</ArticleId><ArticleId IdType="pmc">PMC1364263</ArticleId><ArticleId IdType="pubmed">9767427</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Li J.X., Jin P.F., Wang Y.X., Zhu F.C. Enterovirus 71: A whole virion inactivated enterovirus 71 vaccine. Expert Rev. Vaccines. 2016;15:803&#x2013;813. doi: 10.1080/14760584.2016.1191357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2016.1191357</ArticleId><ArticleId IdType="pubmed">27206811</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q.Y., Wang Y., Bian L., Xu M., Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev. Vaccines. 2016;15:599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S.L., Ying X.L., Han X., Sun X.X., Jin Q., Yang F. Characterization of the enterovirus 71 VP1 protein as a vaccine candidate. J. Med. Virol. 2015;87:256&#x2013;262. doi: 10.1002/jmv.24018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24018</ArticleId><ArticleId IdType="pubmed">25043151</ArticleId></ArticleIdList></Reference><Reference><Citation>Premanand B., Kiener T.K., Meng T., Tan Y.R., Jia Q., Chow V.T., Kwang J. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Antivir. Res. 2012;95:311&#x2013;315. doi: 10.1016/j.antiviral.2012.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.05.017</ArticleId><ArticleId IdType="pubmed">22691220</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P., Hsieh S.Y., Liu C.C., Chou A.H., Chang J.Y., Wu S.C., Liu S.J., Chow Y.H., Su I.J., Klein M. Production of EV71 vaccine candidates. Hum. Vaccines Immunother. 2012;8:1775&#x2013;1783. doi: 10.4161/hv.21739.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.21739</ArticleId><ArticleId IdType="pmc">PMC3656065</ArticleId><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Ye X., Huang X., Cai Y., Liu Q., Li Y., Su Z., Huang Z. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS ONE. 2013;8:1419. doi: 10.1371/journal.pone.0057601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057601</ArticleId><ArticleId IdType="pmc">PMC3579802</ArticleId><ArticleId IdType="pubmed">23451250</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Dong M., Jiang B., Dai X., Meng J. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71. Virus Res. 2012;167:337&#x2013;342. doi: 10.1016/j.virusres.2012.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.05.019</ArticleId><ArticleId IdType="pubmed">22659489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Jiang S., Wang Y. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Biochem. Biophys. Res. Commun. 2013;430:387&#x2013;393. doi: 10.1016/j.bbrc.2012.11.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.11.035</ArticleId><ArticleId IdType="pubmed">23159634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara Y., Kawamura Y.I., Kataoka K., Rahima B., Jackson R.J., Komase K., Dohi T., Boyaka P.N., Takeda Y., Kiyono H., et al. A second generation of double mutant cholera toxin adjuvants: Enhanced immunity without intracellular trafficking. J. Immunol. 2006;177:3045&#x2013;3054. doi: 10.4049/jimmunol.177.5.3045.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.5.3045</ArticleId><ArticleId IdType="pmc">PMC4469177</ArticleId><ArticleId IdType="pubmed">16920941</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L., Xu M., Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antivir. Res. 2013;97:183&#x2013;194. doi: 10.1016/j.antiviral.2012.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.005</ArticleId><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur I., Katyal A. Modification of mouse A2M B (620&#x2013;792) and A2M N (168&#x2013;230) by malondialdehyde and acetaldehyde attenuates the proteinase and TGF-&#x3b2;1 binding ability of A2MB. FEBS Lett. 2011;585:829&#x2013;833. doi: 10.1016/j.febslet.2011.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.02.008</ArticleId><ArticleId IdType="pubmed">21320498</ArticleId></ArticleIdList></Reference><Reference><Citation>Murshid A., Gong J., Calderwood S.K. Hsp90-peptide complexes stimulate antigen presentation through the class II pathway after binding scavenger receptor SREC-I. Immunobiology. 2014;219:924&#x2013;931. doi: 10.1016/j.imbio.2014.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2014.08.001</ArticleId><ArticleId IdType="pmc">PMC4886339</ArticleId><ArticleId IdType="pubmed">25155057</ArticleId></ArticleIdList></Reference><Reference><Citation>Missy K., Hu B., Schilling K., Harenberg A., Sakk V., Kuchenbecker K., Kutsche K., Fischer K.D. &#x3b1;PIX &#x3c1; GTPase guanine nucleotide exchange factor regulates lymphocyte functions and antigen receptor signaling. Mol. Cell. Biol. 2008;28:3776&#x2013;3789. doi: 10.1128/MCB.00507-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00507-07</ArticleId><ArticleId IdType="pmc">PMC2423308</ArticleId><ArticleId IdType="pubmed">18378701</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E.Y., Chavakis E., Czabanka M.A., Langer H.F., Fraemohs L., Economopoulou M., Kundu R.K., Orlandi A., Zheng Y.Y., Prieto D.A., et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science. 2008;322:1101&#x2013;1104. doi: 10.1126/science.1165218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165218</ArticleId><ArticleId IdType="pmc">PMC2753175</ArticleId><ArticleId IdType="pubmed">19008446</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Poel C.E., Spaapen R.M., van de Winkel J.G., Leusen J.H. Functional characteristics of the high affinity IgG receptor, Fc&#x3b3;RI. J. Immunol. 2011;186:2699&#x2013;2704. doi: 10.4049/jimmunol.1003526.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003526</ArticleId><ArticleId IdType="pubmed">21325219</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyre C.A., Barreda M.E., Swink S.L., Fanger M.W. Colocalization of Fc&#x3b3;RI-targeted antigen with class I MHC: Implications for antigen processing. J. Immunol. 2001;166:2469&#x2013;2478. doi: 10.4049/jimmunol.166.4.2469.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.4.2469</ArticleId><ArticleId IdType="pubmed">11160307</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocki P., Morris N.J., Preisinger C., Wang X.N., Kolch W., Multhoff G., Dickinson A.M. Identification of potential HLA class I and class II epitope precursors associated with heat shock protein 70 (HSPA) Cell Stress Chaperones. 2010;15:729&#x2013;741. doi: 10.1007/s12192-010-0184-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-010-0184-z</ArticleId><ArticleId IdType="pmc">PMC3006634</ArticleId><ArticleId IdType="pubmed">20358320</ArticleId></ArticleIdList></Reference><Reference><Citation>Das A., Dinh P.X., Panda D., Pattnaik A.K. Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication. J. Virol. 2014;88:3103&#x2013;3113. doi: 10.1128/JVI.03202-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03202-13</ArticleId><ArticleId IdType="pmc">PMC3957919</ArticleId><ArticleId IdType="pubmed">24371060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi M., Wakita T., Esumi M. 2&#x2032;,5&#x2032;-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. Biochem. Biophys. Res. Commun. 2010;392:397&#x2013;402. doi: 10.1016/j.bbrc.2010.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.01.034</ArticleId><ArticleId IdType="pubmed">20074559</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogden K.M., Hu L., Jha B.K., Sankaran B., Weiss S.R., Silverman R.H., Patton J.T., Prasad B.V. Structural basis for 2&#x2032;,5&#x2032;-oligoadenylate binding and enzyme activity of a viral RNase L antagonist. J. Virol. 2015;89:6633&#x2013;6645. doi: 10.1128/JVI.00701-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00701-15</ArticleId><ArticleId IdType="pmc">PMC4468480</ArticleId><ArticleId IdType="pubmed">25878106</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin L., Howell M.D., Kim B.E., Hall C.F., Streib J.E., Leung D.Y. Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain. J. Allergy Clin. Immunol. 2009;124:270&#x2013;277. doi: 10.1016/j.jaci.2009.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.05.002</ArticleId><ArticleId IdType="pubmed">19577285</ArticleId></ArticleIdList></Reference><Reference><Citation>Nairz M., Fritsche G., Crouch M.L., Barton H.C., Fang F.C., Weiss G. Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition. Cell. Microbiol. 2009;11:1365&#x2013;1381. doi: 10.1111/j.1462-5822.2009.01337.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2009.01337.x</ArticleId><ArticleId IdType="pmc">PMC3467104</ArticleId><ArticleId IdType="pubmed">19500110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrommatis E., Fish E.N., Platanias L.C. The schlafen family of proteins and their regulation by interferons. J. Interferon Cytokine Res. 2013;33:206&#x2013;210. doi: 10.1089/jir.2012.0133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2012.0133</ArticleId><ArticleId IdType="pmc">PMC3624771</ArticleId><ArticleId IdType="pubmed">23570387</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger M., Krebs P., Crozat K., Li X., Croker B.A., Siggs O.M., Popkin D., Du X., Lawson B.R., Theofilopoulos A.N., et al. An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence. Nat. Immunol. 2010;11:335&#x2013;343. doi: 10.1038/ni.1847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1847</ArticleId><ArticleId IdType="pmc">PMC2861894</ArticleId><ArticleId IdType="pubmed">20190759</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zuylen W.J., Garceau V., Idris A., Schroder K., Irvine K.M., Lattin J.E., Ovchinnikov D.A., Perkins A.C., Cook A.D., Hamilton J.A., et al. Macrophage activation and differentiation signals regulate schlafen-4 gene expression: Evidence for schlafen-4 as a modulator of myelopoiesis. PLoS ONE. 2011;6:1419. doi: 10.1371/journal.pone.0015723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015723</ArticleId><ArticleId IdType="pmc">PMC3017543</ArticleId><ArticleId IdType="pubmed">21249125</ArticleId></ArticleIdList></Reference><Reference><Citation>Leopold Wager C.M., Hole C.R., Wozniak K.L., Olszewski M.A., Wormley F.L., Jr. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J. Immunol. 2014;193:4060&#x2013;4071. doi: 10.4049/jimmunol.1400318.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400318</ArticleId><ArticleId IdType="pmc">PMC4185263</ArticleId><ArticleId IdType="pubmed">25200956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce G., Angeli V., Randolph G.J., Junt T., von Andrian U., Schnittler H.J., Jessberger R. Signaling protein SWAP-70 is required for efficient B cell homing to lymphoid organs. Nat. Immunol. 2006;7:827&#x2013;834. doi: 10.1038/ni1365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1365</ArticleId><ArticleId IdType="pubmed">16845395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocana-Morgner C., Gotz A., Wahren C., Jessberger R. SWAP-70 restricts spontaneous maturation of dendritic cells. J. Immunol. 2013;190:5545&#x2013;5558. doi: 10.4049/jimmunol.1203095.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1203095</ArticleId><ArticleId IdType="pubmed">23636062</ArticleId></ArticleIdList></Reference><Reference><Citation>Simeoni L., Bogeski I. Redox regulation of T-cell receptor signaling. Biol. Chem. 2015;396:555&#x2013;568. doi: 10.1515/hsz-2014-0312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2014-0312</ArticleId><ArticleId IdType="pubmed">25781677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaihami G.H., Almeida J.R., Santos S.S., Netto L.E., Almeida S.R., Baldini R.L. Involvement of a 1-Cys peroxiredoxin in bacterial virulence. PLoS Pathog. 2014;10:1419. doi: 10.1371/journal.ppat.1004442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004442</ArticleId><ArticleId IdType="pmc">PMC4199769</ArticleId><ArticleId IdType="pubmed">25329795</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon D., Coll R., O&#x2019;Neill L.A., Board P.G. Glutathione transferase &#x3c9; 1 is required for the lipopolysaccharide-stimulated induction of NADPH oxidase 1 and the production of reactive oxygen species in macrophages. Free Radic. Biol. Med. 2014;73:318&#x2013;327. doi: 10.1016/j.freeradbiomed.2014.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.05.020</ArticleId><ArticleId IdType="pubmed">24873723</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon D., Coll R., O&#x2019;Neill L.A., Board P.G. GSTO1-1 modulates metabolism in macrophages activated through the LPS and TLR4 pathway. J. Cell Sci. 2015;128:1982&#x2013;1990. doi: 10.1242/jcs.167858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.167858</ArticleId><ArticleId IdType="pubmed">25908843</ArticleId></ArticleIdList></Reference><Reference><Citation>Heraud-Farlow J.E., Kiebler M.A. The multifunctional Staufen proteins: Conserved roles from neurogenesis to synaptic plasticity. Trends Neurosci. 2014;37:470&#x2013;479. doi: 10.1016/j.tins.2014.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2014.05.009</ArticleId><ArticleId IdType="pmc">PMC4156307</ArticleId><ArticleId IdType="pubmed">25012293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambayashi T., Kraft-Leavy J.R., Dauner J.G., Sullivan B.A., Laur O., Jensen P.E. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes. J. Immunol. 2004;172:1661&#x2013;1669. doi: 10.4049/jimmunol.172.3.1661.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.3.1661</ArticleId><ArticleId IdType="pubmed">14734748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mester G., Hoffmann V., Stevanovic S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell. Mol. Life Sci. 2011;68:1521&#x2013;1532. doi: 10.1007/s00018-011-0659-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-011-0659-9</ArticleId><ArticleId IdType="pmc">PMC11114492</ArticleId><ArticleId IdType="pubmed">21387142</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleeson P.A. The role of endosomes in innate and adaptive immunity. Semin. Cell Dev. Biol. 2014;31:64&#x2013;72. doi: 10.1016/j.semcdb.2014.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2014.03.002</ArticleId><ArticleId IdType="pubmed">24631355</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wijk S.J., Timmers H.T. The family of ubiquitin-conjugating enzymes (E2s): Deciding between life and death of proteins. FASEB J. 2010;24:981&#x2013;993. doi: 10.1096/fj.09-136259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-136259</ArticleId><ArticleId IdType="pubmed">19940261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessat M., Knudsen G., Burlingame A.L., Wang C.C. A minimal anaphase promoting complex/cyclosome (APC/C) in Trypanosoma brucei. PLoS ONE. 2013;8:1419. doi: 10.1371/annotation/d048ae1b-6a9b-4353-bdf2-c707925ce37c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/d048ae1b-6a9b-4353-bdf2-c707925ce37c</ArticleId><ArticleId IdType="pmc">PMC3606461</ArticleId><ArticleId IdType="pubmed">23533609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias M., Blanc C., Thazar-Poulot N., Ben Larbi S., Cosson P., Letourneur F. Dictyostelium ACAP-A is an ArfGAP involved in cytokinesis, cell migration and actin cytoskeleton dynamics. J. Cell Sci. 2013;126:756&#x2013;766. doi: 10.1242/jcs.113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.113951</ArticleId><ArticleId IdType="pubmed">23264736</ArticleId></ArticleIdList></Reference><Reference><Citation>Seuter S., Ryynanen J., Carlberg C. The ASAP2 gene is a primary target of 1,25-dihydroxyvitamin D3 in human monocytes and macrophages. J. Steroid Biochem. Mol. Biol. 2014;144:12&#x2013;18. doi: 10.1016/j.jsbmb.2013.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2013.08.014</ArticleId><ArticleId IdType="pubmed">23999061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjay A., Horne W.C., Baron R. The Cbl family: Ubiquitin ligases regulating signaling by tyrosine kinases. Sci. STKE. 2001;2001:pe40. doi: 10.1126/stke.2001.110.pe40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/stke.2001.110.pe40</ArticleId><ArticleId IdType="pubmed">11724969</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyasova M.S., Ma K., Lipkowitz S. Molecular pathways: Cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment. Clin. Cancer Res. 2015;21:1789&#x2013;1794. doi: 10.1158/1078-0432.CCR-13-2490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-13-2490</ArticleId><ArticleId IdType="pmc">PMC4401614</ArticleId><ArticleId IdType="pubmed">25477533</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Zhou H., Langdon W.Y., Zhang J. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity. Cell Cycle. 2014;13:1875&#x2013;1884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4111751</ArticleId><ArticleId IdType="pubmed">24875217</ArticleId></ArticleIdList></Reference><Reference><Citation>Spang N., Feldmann A., Huesmann H., Bekbulat F., Schmitt V., Hiebel C., Koziollek-Drechsler I., Clement A.M., Moosmann B., Jung J., et al. RAB3GAP1 and RAB3GAP2 modulate basal and rapamycin-induced autophagy. Autophagy. 2014;10:2297&#x2013;2309. doi: 10.4161/15548627.2014.994359.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/15548627.2014.994359</ArticleId><ArticleId IdType="pmc">PMC4502700</ArticleId><ArticleId IdType="pubmed">25495476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochrainer K., Kroismayr R., Baranyi U., Binder B.R., Lipp J. Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B. Cell. Mol. Life Sci. 2008;65:2105&#x2013;2117. doi: 10.1007/s00018-008-8148-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-008-8148-5</ArticleId><ArticleId IdType="pmc">PMC11131906</ArticleId><ArticleId IdType="pubmed">18535780</ArticleId></ArticleIdList></Reference><Reference><Citation>Goueli B.S., Powell M.B., Finger E.C., Pfeffer S.R. TBC1D16 is a Rab4A GTPase activating protein that regulates receptor recycling and EGF receptor signaling. Proc. Natl. Acad. Sci. USA. 2012;109:15787&#x2013;15792. doi: 10.1073/pnas.1204540109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1204540109</ArticleId><ArticleId IdType="pmc">PMC3465424</ArticleId><ArticleId IdType="pubmed">23019362</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Jiang X., Luo Z. WWP2: A multifunctional ubiquitin ligase gene. Pathol. Oncol. Res. 2014;20:799&#x2013;803. doi: 10.1007/s12253-014-9838-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12253-014-9838-y</ArticleId><ArticleId IdType="pubmed">25216927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanoa B.S., Cogliati T., Satish A.G., Bruford E.A., Friedman J.S. Update on the Kelch-like (KLHL) gene family. Hum. Genom. 2013;7:13. doi: 10.1186/1479-7364-7-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-7364-7-13</ArticleId><ArticleId IdType="pmc">PMC3658946</ArticleId><ArticleId IdType="pubmed">23676014</ArticleId></ArticleIdList></Reference><Reference><Citation>Willinger T., Staron M., Ferguson S.M., de Camilli P., Flavell R.A. Dynamin 2-dependent endocytosis sustains T-cell receptor signaling and drives metabolic reprogramming in T lymphocytes. Proc. Natl. Acad. Sci. USA. 2015;112:4423&#x2013;4428. doi: 10.1073/pnas.1504279112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1504279112</ArticleId><ArticleId IdType="pmc">PMC4394306</ArticleId><ArticleId IdType="pubmed">25831514</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim J.H., Xiao C., Hayden M.S., Lee K.Y., Trombetta E.S., Pypaert M., Nara A., Yoshimori T., Wilm B., Erdjument-Bromage H., et al. CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis. J. Cell Biol. 2006;172:1045&#x2013;1056. doi: 10.1083/jcb.200509041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200509041</ArticleId><ArticleId IdType="pmc">PMC2063762</ArticleId><ArticleId IdType="pubmed">16567502</ArticleId></ArticleIdList></Reference><Reference><Citation>Posey A.D., Jr., Swanson K.E., Alvarez M.G., Krishnan S., Earley J.U., Band H., Pytel P., McNally E.M., Demonbreun A.R. EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Dev. Biol. 2014;387:179&#x2013;190. doi: 10.1016/j.ydbio.2014.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2014.01.004</ArticleId><ArticleId IdType="pmc">PMC3987670</ArticleId><ArticleId IdType="pubmed">24440153</ArticleId></ArticleIdList></Reference><Reference><Citation>Galletta B.J., Mooren O.L., Cooper J.A. Actin dynamics and endocytosis in yeast and mammals. Curr. Opin. Biotechnol. 2010;21:604&#x2013;610. doi: 10.1016/j.copbio.2010.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2010.06.006</ArticleId><ArticleId IdType="pmc">PMC2952672</ArticleId><ArticleId IdType="pubmed">20637595</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchhausen T., Owen D., Harrison S.C. Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb. Perspect. Biol. 2014;6:a016725. doi: 10.1101/cshperspect.a016725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a016725</ArticleId><ArticleId IdType="pmc">PMC3996469</ArticleId><ArticleId IdType="pubmed">24789820</ArticleId></ArticleIdList></Reference><Reference><Citation>Moravec R., Conger K.K., D&#x2019;Souza R., Allison A.B., Casanova J.E. BRAG2/GEP100/IQSec1 interacts with clathrin and regulates &#x3b1;5&#x3b2;1 integrin endocytosis through activation of ADP ribosylation factor 5 (Arf5) J. Biol. Chem. 2012;287:31138&#x2013;31147. doi: 10.1074/jbc.M112.383117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.383117</ArticleId><ArticleId IdType="pmc">PMC3438945</ArticleId><ArticleId IdType="pubmed">22815487</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond C.K., Howald-Stevenson I., Vater C.A., Stevens T.H. Morphological classification of the yeast vacuolar protein sorting mutants: Evidence for a prevacuolar compartment in class E vps mutants. Mol. Biol. Cell. 1992;3:1389&#x2013;1402. doi: 10.1091/mbc.3.12.1389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.3.12.1389</ArticleId><ArticleId IdType="pmc">PMC275707</ArticleId><ArticleId IdType="pubmed">1493335</ArticleId></ArticleIdList></Reference><Reference><Citation>Feyder S., De Craene J.O., Bar S., Bertazzi D.L., Friant S. Membrane trafficking in the yeast Saccharomyces cerevisiae model. Int. J. Mol. Sci. 2015;16:1509&#x2013;1525. doi: 10.3390/ijms16011509.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms16011509</ArticleId><ArticleId IdType="pmc">PMC4307317</ArticleId><ArticleId IdType="pubmed">25584613</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrizzo A., Conte C., Tagliamonte M., Napolitano M., Bifulco K., Carriero V., de Stradis A., Tornesello M.L., Buonaguro F.M., Quaglia F., et al. Functional characterization of biodegradable nanoparticles as antigen delivery system. J. Exp. Clin. Cancer Res. 2015;34:114. doi: 10.1186/s13046-015-0231-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-015-0231-9</ArticleId><ArticleId IdType="pmc">PMC4596393</ArticleId><ArticleId IdType="pubmed">26444005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.P., Chang K.S., Hsu J.L., Tsai I.F., Lin A.B., Wei T.Y., Wu C.L., Lu Y.T. Analysis of the immune response of human dendritic cells to Mycobacterium tuberculosis by quantitative proteomics. Proteome Sci. 2016;14:5. doi: 10.1186/s12953-016-0095-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12953-016-0095-8</ArticleId><ArticleId IdType="pmc">PMC4782377</ArticleId><ArticleId IdType="pubmed">26957948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagafuku M., Okuyama K., Onimaru Y., Suzuki A., Odagiri Y., Yamashita T., Iwasaki K., Fujiwara M., Takayanagi M., Ohno I., et al. CD4 and CD8 T-cells require different membrane gangliosides for activation. Proc. Natl. Acad. Sci. USA. 2012;109:E336&#x2013;E342. doi: 10.1073/pnas.1114965109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1114965109</ArticleId><ArticleId IdType="pmc">PMC3277553</ArticleId><ArticleId IdType="pubmed">22308377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji T., Honda T., Miwatani T., Wakabayashi S., Matsubara H. Analysis of receptor-binding site in Escherichia coli enterotoxin. J. Biol. Chem. 1985;260:8552&#x2013;8558.</Citation><ArticleIdList><ArticleId IdType="pubmed">3924916</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Xu N., Yuan H., Li S., Liu L., Pu Z., Wan J., Wang H., Chang Y., Li R. Immunomodulatory activity of recombinant ricin toxin binding subunit B (RTB) Int. J. Mol. Sci. 2013;14:12401&#x2013;12410. doi: 10.3390/ijms140612401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms140612401</ArticleId><ArticleId IdType="pmc">PMC3709792</ArticleId><ArticleId IdType="pubmed">23765218</ArticleId></ArticleIdList></Reference><Reference><Citation>Adhya D., Dutta K., Kundu K., Basu A. Histone deacetylase inhibition by Japanese encephalitis virus in monocyte/macrophages: A novel viral immune evasion strategy. Immunobiology. 2013;218:1235&#x2013;1247. doi: 10.1016/j.imbio.2013.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2013.04.018</ArticleId><ArticleId IdType="pubmed">23706498</ArticleId></ArticleIdList></Reference><Reference><Citation>Cafri G., Amram E., Rinott G., Koifman G., Fishman S., Keisari Y., Tzehoval E., Margalit A., Eisenbach L., Gross G. Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene. Int. Immunol. 2011;23:453&#x2013;461. doi: 10.1093/intimm/dxr033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxr033</ArticleId><ArticleId IdType="pubmed">21652516</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Wang F., Guo Y., Zhou Q., Wang Y., Yin Y., Sun S. Enhanced capacity of antigen presentation of HBc-VLP-pulsed RAW264.7 cells revealed by proteomics analysis. J. Proteome Res. 2008;7:4898&#x2013;4903. doi: 10.1021/pr800547v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr800547v</ArticleId><ArticleId IdType="pubmed">18842007</ArticleId></ArticleIdList></Reference><Reference><Citation>Preshaw P.M., Taylor J.J. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J. Clin. Periodontol. 2011;38:60&#x2013;84. doi: 10.1111/j.1600-051X.2010.01671.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2010.01671.x</ArticleId><ArticleId IdType="pubmed">21323705</ArticleId></ArticleIdList></Reference><Reference><Citation>Peti W., Page R. Molecular basis of MAP kinase regulation. Protein Sci. 2013;22:1698&#x2013;1710. doi: 10.1002/pro.2374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.2374</ArticleId><ArticleId IdType="pmc">PMC3843625</ArticleId><ArticleId IdType="pubmed">24115095</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 2002;20:55&#x2013;72. doi: 10.1146/annurev.immunol.20.091301.131133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.20.091301.131133</ArticleId><ArticleId IdType="pubmed">11861597</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Ren J., Xiao X., Tang Y.Y., Weng H.Q., Yang Q., Wu M.J., Tang W. Proteomic analysis of bladder cancer by iTRAQ after Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene treatment. Biol. Chem. 2013;394:1333&#x2013;1342. doi: 10.1515/hsz-2013-0201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2013-0201</ArticleId><ArticleId IdType="pubmed">23893687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H., Muruganujan A., Casagrande J.T., Thomas P.D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 2013;8:1551&#x2013;1566. doi: 10.1038/nprot.2013.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.092</ArticleId><ArticleId IdType="pmc">PMC6519453</ArticleId><ArticleId IdType="pubmed">23868073</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschini A., Szklarczyk D., Frankild S., Kuhn M., Simonovic M., Roth A., Lin J., Minguez P., Bork P., von Mering C., et al. STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808&#x2013;D815. doi: 10.1093/nar/gks1094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1094</ArticleId><ArticleId IdType="pmc">PMC3531103</ArticleId><ArticleId IdType="pubmed">23203871</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>